GEO Group sells three Adelanto ICE facilities to US government for $950 million
Bitget2026/10/05 10:56GEO completed the sale of the Adelanto, California ICE processing center complex to the US government for USD 950 million. The complex includes three facilities totaling 2,644 beds; GEO expects about USD 705 million of net proceeds after taxes and fees. Support services are set to continue under the existing ICE contract, effective through Dec. 19, 2034, including an option period. Net proceeds are earmarked for debt reduction, share repurchases, and general corporate purposes. Share repurchase authorization was increased by USD 750 million to USD 1.25 billion, effective through Dec. 31, 2029. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The GEO Group Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610050655BIZWIRE_USPR_____20261002_BW355749) on October 05, 2026, and is solely responsible for the information contained therein.
- GEO completed the sale of the Adelanto, California ICE processing center complex to the US government for USD 950 million.
- The complex includes three facilities totaling 2,644 beds; GEO expects about USD 705 million of net proceeds after taxes and fees.
- Support services are set to continue under the existing ICE contract, effective through Dec. 19, 2034, including an option period.
- Net proceeds are earmarked for debt reduction, share repurchases, and general corporate purposes.
- Share repurchase authorization was increased by USD 750 million to USD 1.25 billion, effective through Dec. 31, 2029.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver price today: Silver broadly unchanged, according to FXStreet data
IREM names Kim Woo-jin, Sung Young-chul, Lee Hyung-do as director nominees in corrected filing
IREM issued a correction to its Sept. 4 board resolution calling an extraordinary shareholders’ meeting, updating the agenda to specify three director appointments. The meeting is scheduled for Oct. 21 at 9 a.m. at the company’s headquarters in Buan, North Jeolla Province. The revised slate includes the reappointment of CEO Woojin Kim as an inside director for a three-year term. The revised slate includes the appointment of Youngcheol Seong as an inside director for a three-year term. The revised slate includes the appointment of Hyungdo Lee as an independent director for a three-year term. The correction dated Oct. 6 was filed to reflect the finalized agenda items. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IREM Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006900738), on October 06, 2026, and is solely responsible for the information contained therein.
TRex Bio (TRXB.US) IPO priced at $14-16 per share, plans to raise $125 million; Eli Lilly intends to subscribe for $13 million
TRex Bio announced the terms of its initial public offering (IPO) on Monday.
Brazilian Election Trading Manual: How We Predicted This Round's Surge
Crypto prices
More
